Azilsartan National NME Drug Monograph

Secondary HTN Sitting DBP > 114 mm Hg, significant or unstable CV disease, significant kidney (eGFR < 30 mL/min/1.73 m2) , metabolic, hepatic, or psychiatric disorder, type 1 or poorly controlled type 2 DM (Hgb A1c > 8%), night shift workers, pregnant or nursing females or women of child-bearing potential not using medically approved contraception ................
................